Literature DB >> 16401471

Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain.

Anthony R Hobson1, Paul L Furlong, Sanchoy Sarkar, Philip J M Matthews, Robert P Willert, Sian F Worthen, Barbara J Unsworth, Qasim Aziz.   

Abstract

BACKGROUND & AIMS: Esophageal hypersensitivity is thought to be important in the generation and maintenance of symptoms in noncardiac chest pain (NCCP). In this study, we explored the neurophysiologic basis of esophageal hypersensitivity in a cohort of NCCP patients.
METHODS: We studied 12 healthy controls (9 women; mean age, 37.1 +/- 8.7 y) and 32 NCCP patients (23 women; mean age, 47.2 +/- 10 y). All had esophageal manometry, esophageal evoked potentials to electrical stimulation, and NCCP patients had 24-hour ambulatory pH testing.
RESULTS: The NCCP patients had reduced pain thresholds (PT) (72.1 +/- 19.4 vs 54.2 +/- 23.6, P = .02) and increased P1 latencies (P1 = 105.5 +/- 11.1 vs 118.1 +/- 23.4, P = .02). Subanalysis showed that the NCCP group could be divided into 3 distinct phenotypic classifications. Group 1 had reduced pain thresholds in conjunction with normal/reduced latency P1 latencies (n = 9). Group 2 had reduced pain thresholds in conjunction with increased (>2.5 SD) P1 latencies (n = 7), and group 3 had normal pain thresholds in conjunction with either normal (n = 10) or increased (>2.5 SD, n = 3) P1 latencies.
CONCLUSIONS: Normal esophageal evoked potential latencies with reduced PT, as seen in group 1 patients, is indicative of enhanced afferent transmission and therefore increased esophageal afferent pathway sensitivity. Increased esophageal evoked potential latencies with reduced PT in group 2 patients implies normal afferent transmission to the cortex but heightened secondary cortical processing of this information, most likely owing to psychologic factors such as hypervigilance. This study shows that NCCP patients with esophageal hypersensitivity may be subclassified into distinct phenotypic subclasses based on sensory responsiveness and objective neurophysiologic profiles.

Entities:  

Mesh:

Year:  2006        PMID: 16401471     DOI: 10.1053/j.gastro.2005.10.016

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Treatment of esophageal (noncardiac) chest pain: an expert review.

Authors:  Enrique Coss-Adame; Askin Erdogan; Satish S C Rao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-28       Impact factor: 11.382

2.  Noncardiac chest pain: current treatment.

Authors:  Ron Schey; Autumn Villarreal; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

3.  A Review of Esophageal Chest Pain.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-11

Review 4.  New technologies to investigate the brain-gut axis.

Authors:  Abhishek Sharma; Dina Lelic; Christina Brock; Peter Paine; Qasim Aziz
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

5.  The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment.

Authors:  Christian Lottrup; Søren Schou Olesen; Asbjørn Mohr Drewes
Journal:  Gastroenterol Res Pract       Date:  2011-08-02       Impact factor: 2.260

6.  Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain.

Authors:  Muhammad Hafeez; Ehsan Kadir; Anjum Aijaz
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

7.  Rectal hyposensitivity.

Authors:  Rebecca E Burgell; S Mark Scott
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

Review 8.  Guidelines on the irritable bowel syndrome: mechanisms and practical management.

Authors:  R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell
Journal:  Gut       Date:  2007-05-08       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.